We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GKOS icon
5776
Glaukos
GKOS
$10.1B
$48K ﹤0.01%
1,457
+1,020
+233% +$38.7K
LQDT icon
5777
Liquidity Services
LQDT
$1.23B
$48K ﹤0.01%
8,231
+6,661
+424% +$40.6K
MTRX icon
5778
Matrix Service
MTRX
$336M
$48K ﹤0.01%
3,119
+1,301
+72% +$14.8K
NERV icon
5779
Minerva Neurosciences
NERV
$185M
$48K ﹤0.01%
785
+727
+1,253% +$41.7K
PRPH
5780
DELISTED
ProPhase Labs
PRPH
$48K ﹤0.01%
2,210
+1,097
+99% +$23.6K
UFPT icon
5781
UFP Technologies
UFPT
$2.07B
$48K ﹤0.01%
1,718
+1,114
+184% +$30.8K
MODN
5782
DELISTED
MODEL N, INC.
MODN
$48K ﹤0.01%
3,219
-234,142
-99% -$3.13M
DBGR
5783
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
$48K ﹤0.01%
1,724
-92
-5% -$2.48K
TWNK
5784
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$48K ﹤0.01%
3,527
+1,027
+41% +$14.8K
AVID
5785
DELISTED
Avid Technology Inc
AVID
$48K ﹤0.01%
10,631
+919
+9% +$4.36K
NH
5786
DELISTED
NantHealth, Inc
NH
$48K ﹤0.01%
774
+509
+192% +$29.8K
AOIL
5787
DELISTED
Aberdeen Standard Bloomberg WTI Crude Oil Strategy K-1 Free ETF
AOIL
$48K ﹤0.01%
1,940
-60
-3% -$1.44K
NITE
5788
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$48K ﹤0.01%
+2,505
New +$54.1K
CNXT icon
5789
VanEck ChiNext Innovators ETF
CNXT
$107M
$47K ﹤0.01%
1,381
+288
+26% +$9.36K
HNRG icon
5790
Hallador Energy
HNRG
$704M
$47K ﹤0.01%
8,250
+6,486
+368% +$42.1K
PEBK icon
5791
Peoples Bancorp of North Carolina
PEBK
$231M
$47K ﹤0.01%
1,433
-789
-36% -$22.8K
ZLAB icon
5792
Zai Lab
ZLAB
$2.05B
$47K ﹤0.01%
+1,735
New +$48.4K
RJZ
5793
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Metals Total Return
RJZ
$47K ﹤0.01%
5,686
-44,299
-89% -$369K
TMX
5794
PUT
DELISTED
Terminix Global Holdings, Inc.
TMX
$47K ﹤0.01%
1,493
+299
+25% +$8.82K
ZMLP
5795
DELISTED
Direxion Zacks MLP High Income Index Shares
ZMLP
$47K ﹤0.01%
351
BHBK
5796
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$47K ﹤0.01%
2,450
+538
+28% +$10K
IO
5797
DELISTED
ION Geophysical Corporation
IO
$47K ﹤0.01%
4,992
-2,007
-29% -$12.1K
GSP
5798
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$47K ﹤0.01%
3,355
+2,278
+212% +$30.3K
CEFL
5799
DELISTED
ETRACS Monthly Pay 2xLeveraged Closed-End Fund ETN
CEFL
$47K ﹤0.01%
+2,508
New +$46K
CHOC
5800
DELISTED
iPath Pure Beta Cocoa ETN
CHOC
$47K ﹤0.01%
1,553
+1,095
+239% +$31.8K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.